Effect of statil (ICI 128436) on erythrocyte viscosity in vitro
- 1 April 1988
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 37 (4) , 471-475
- https://doi.org/10.2337/diabetes.37.4.471
Abstract
The hypothesis that sorbitol accumulation could contribute to a reduced erythrocyte deformability in diabetes was investigated. Erythrocyte sorbitol and erythrocyte viscosity at high and low shear rates were studied in 20 insulin-dependent diabetic (IDDM) and 20 matched control subjects. An increased erythrocyte sorbitol and an increased low-shear erythrocyte viscosity were found in the IDDM patients, but there was no significant correlation ( r = .11, NS) between the parameters. Incubation (3 h, 37 degrees C) in a Krebs buffer containing 33.3 mM glucose resulted in a significant sorbitol accumulation, but erythrocyte viscosity was not affected. Despite this fact, addition of 1 mM statil (ICI 128436) in the 5.5- and 33.3-mM glucose media not only prevented erythrocyte sorbitol accumulation but also improved erythrocyte viscosity in diabetic and control subjects. The effect was more pronounced at the low (∼16%) than at the high (∼2%) shear rate. The effect on erythrocyte viscosity disappeared by washing the erythrocytes after incubation, although erythrocyte sorbitol remained different. Our results suggest that sorbitol accumulation does not contribute to an increased erythrocyte viscosity in diabetes, and statil shows a positive effect on erythrocyte viscosity independent of its aldose reductase–inhibiting property.This publication has 7 references indexed in Scilit:
- ERYTHROCYTE SORBITOL CONTENT IN DIABETIC-PATIENTS - RELATION TO METABOLIC CONTROL1987
- Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus.Journal of Clinical Pathology, 1986
- Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the ratMetabolism, 1985
- RCapillaries: Basement Membrane Thickening by Galactosemia Prevented with Aldose Reductase InhibitorScience, 1983
- PHARMACOPHORE REQUIREMENTS OF THE ALDOSE REDUCTASE INHIBITOR SITE1983
- Rheological Properties of Erythrocytes in Heterozygous and Homozygous β ThalassaemiaBritish Journal of Haematology, 1979
- Reduced Erythrocyte Deformability in DiabetesDiabetes, 1978